Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Lewy body dementia

Topic: Brain proteins, microglia and lab models

The mean age of the 3 women and 18 men was 50 years (range, 26-68 years). Seven patients were found to have venous stenosis. Endovascular stent placement of moderate to high-grade azygos vein stenosis in 3 patients resulted in prompt and remarkable improvement of symptoms in 2 patients (SIHDAS: very severe disability to no or mild disability) and mild improvement in 1 patient (SIHDAS: very severe disability to severe disability). Treatment of internal jugular vein and inferior vena cava stenosis in 2 patients each did not result in any improvement of symptoms. Endovascular (5 patients) or surgical (2 patients) interruption of multiple epidural spinal venous pathways did not result in any clinical improvement. The azygos vein is the main conduit between the spinal CSF space and the systemic venous circulation and this study demonstrates that isolated azygos vein stenosis may be a cause of spinal CSF loss and sagging brain syndrome. In this study, the yield of finding a clinically important treatable venous lesion among patients with recalcitrant bvFTD sagging brain syndrome was relatively low (15%). However, high quality and safe noninvasive imaging of the systemic venous system is available, eg, MR-venography, and should be considered for those patients who have exhausted treatments for this devastating condition, focusing on the azygos system.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Schievink, W. I., Maya, M. M., Saouaf, R., LIPSHUTZ, H., Taché, R. B., Scoffings, D. J., et al. (2025). Azygos Vein Stenosis in Frontotemporal Dementia Sagging Brain Syndrome. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8532

Vancouver

Schievink WI, Maya MM, Saouaf R, LIPSHUTZ H, Taché RB, Scoffings DJ, et al. Azygos Vein Stenosis in Frontotemporal Dementia Sagging Brain Syndrome. American Journal of Neuroradiology. 2025. doi:10.3174/ajnr.a8532. PMID: 39848780.

BibTeX

@article{schievink2025-39848780,
  author  = {Schievink, Wouter I. and Maya, M. Marcel and Saouaf, Rola and LIPSHUTZ, HERBERT and Taché, Rachelle B. and Scoffings, Daniel J. and Schmahmann, Jeremy Dan},
  title   = {{Azygos Vein Stenosis in Frontotemporal Dementia Sagging Brain Syndrome}},
  journal = {American Journal of Neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a8532},
  pmid    = {39848780},
  url     = {https://doi.org/10.3174/ajnr.a8532}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

In this small study of 21 patients, endovascular stent placement of moderate to high-grade azygos vein stenosis resulted in improvement of symptoms in some patients, but the yield of finding a clinically important treatable venous lesion was relatively low at 15%. This is a small, preliminary study and does not establish a treatment, cure or prevention for frontotemporal dementia.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 3 of 4; Institution's track record 3 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (American Journal of Neuroradiology)
Journal's citation record 2 / 4 American Journal of Neuroradiology: journal h-index 182 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Jeremy Dan Schmahmann: h-index 89 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39848780)
Free to read 2 / 2 Free to read
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Lewy body dementia

Also tagged “bodies”

1,017 studies in the library carry the topic tag “bodies”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Lewy body dementia

See all studies in Lewy body dementia →